In ascites fluid from a cohort of mixed KRAS-positive and wild-type tumours, KRAS mutations were detected in 100% of the KRAS-positive cohort, and in an additional 19% of tumours deemed wild-type by tissue biopsy [34]. Here, KRAS is linked to neoplasm.